Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Questions and Answers Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 20, 2018
April 14, 2020
1600b7d2-35c2-41f8-add1-35f8c98ddb9b
Related Documents
Identification of Manufacturing Establishments in Applications Submitted to CBER and CDER Questions and Answers
Guidance DocumentOctober 22, 2019Center for Drug Evaluation and Research
Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Guidance for Industry
Guidance DocumentSeptember 30, 2016Center for Drug Evaluation and Research
E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers
Guidance DocumentJuly 19, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.